A report from bioLIVE has forecasted that outsourcing will play an increasing role in the bio supply chain and that continuous manufacturing, API and process analytical technology (PAT) expertise will be vital to future growth.
Here, we speak with Sergey Lazarev, general director of AirBridgeCargo Airlines about logistics in the pharma market, what it means to be an IATA CEIV Pharma-certified company and the future of pharma transportation.
Howorth Air Technology and Russell Finex reveal how combining their expertise allowed them to create multiple customised solutions for a new production facility.
In this online exclusive, Mike Novotny of Medrio, looks at the rise of real-world data as a result of patient centric approaches and movement towards precision medicine, and how new tech may help with collection and analysis.
It’s that time of year again when we find out who has been given the prestigious Queen’s Awards for Enterprise for outstanding achievements in four main categories. This year has seen a record number of those granted for international trade, here, we
Here, Tony Hitchcock, technical director at Cobra Biologics and Joanne Anderson, business development director at Symbiosis, discuss the challenges associated with manufacturing for gene therapies.
Here, Steve Lyon, digital lead, Communities & Content, Allied Market Research (AMR), discusses some examples of new technology in the ADC space and the ground-breaking potential this new class of drugs will have in the treatment of cancer
We speak with Chapper healthcare’s warehouse manager, Stephen Prior, about overcoming the logistical challenges of shipping medicines around the globe and the packaging solutions his team utilise to overcome every eventuality, including the weather.
Here, Paul Terry, director of sales EMEA at Peli BioThermal, goes into more detail about how the right approach to packaging can help keep medicines affordable for those in developing countries…
Higher level apprenticeships have hit a four-year high across the pharmaceutical industry, according to a new survey into links between industry and academia by the Association of the British Pharmaceutical Industry (ABPI).
In order to reduce the high level of disabilities and stroke recurrence in cases of acute ischaemic stroke (AIS) it is vital that the diverse unmet needs are addressed, according to data and analytics company, GlobalData.
David O’Connell, director Pharmaceutical Development at PCI Pharma Services discusses the advantages of dry granulation as an alternative to traditional wet granulation for the development and manufacturing of solid oral dosage forms…